These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 7441216)

  • 21. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
    J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
    Mathew E; Sanderson CM; Hollinshead M; Smith GL
    J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cytochalasin D and monensin on enveloped vaccinia virus release.
    Payne LG; Kristensson K
    Arch Virol; 1982; 74(1):11-20. PubMed ID: 6891579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
    Blasco R; Moss B
    J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model.
    Law M; Pütz MM; Smith GL
    J Gen Virol; 2005 Apr; 86(Pt 4):991-1000. PubMed ID: 15784892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
    Herrera E; Lorenzo MM; Blasco R; Isaacs SN
    J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single radial immunodiffusion test for detecting antibodies against surface antigens of intracellular and extracellular vaccinia virus.
    Prakash VJ; Norrby E; Payne L
    J Gen Virol; 1977 Jun; 35(3):465-72. PubMed ID: 407326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing poxvirus oncolytic effects through increased spread and immune evasion.
    Kirn DH; Wang Y; Liang W; Contag CH; Thorne SH
    Cancer Res; 2008 Apr; 68(7):2071-5. PubMed ID: 18381410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope.
    Ravanello MP; Hruby DE
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1479-83. PubMed ID: 8207414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release.
    Meiser A; Boulanger D; Sutter G; Krijnse Locker J
    J Gen Virol; 2003 Jun; 84(Pt 6):1383-1392. PubMed ID: 12771405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.
    Sodeik B; Doms RW; Ericsson M; Hiller G; Machamer CE; van 't Hof W; van Meer G; Moss B; Griffiths G
    J Cell Biol; 1993 May; 121(3):521-41. PubMed ID: 8486734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glycosylation inhibitors on the release of enveloped vaccinia virus.
    Payne LG; Kristensson K
    J Virol; 1982 Feb; 41(2):367-75. PubMed ID: 7077747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.
    Doceul V; Hollinshead M; Breiman A; Laval K; Smith GL
    J Gen Virol; 2012 Sep; 93(Pt 9):1876-1886. PubMed ID: 22622330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
    Isaacs SN; Wolffe EJ; Payne LG; Moss B
    J Virol; 1992 Dec; 66(12):7217-24. PubMed ID: 1433514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
    Lorenzo MM; Herrera E; Blasco R; Isaacs SN
    Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
    Smith GL; Vanderplasschen A
    Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread.
    Law M; Hollinshead R; Smith GL
    J Gen Virol; 2002 Jan; 83(Pt 1):209-222. PubMed ID: 11752718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smallpox virus plaque phenotypes: genetic, geographical and case fatality relationships.
    Olson VA; Karem KL; Smith SK; Hughes CM; Damon IK
    J Gen Virol; 2009 Apr; 90(Pt 4):792-798. PubMed ID: 19264626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The existence of an envelope on extracellular cowpox virus and its antigenic relationship to the vaccinia envelope.
    Payne LG
    Arch Virol; 1986; 90(1-2):125-33. PubMed ID: 3729722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
    Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
    J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.